CRNX R&D to Revenue
Crinetics Pharmaceuticals Inc · R&D to Revenue
CRNX R&D to Revenue
Latest reported4314.68%period ending
CRNX FY R&D/Revenue (865.87% → 4314.68%)
Latest values, visible window
High-resolution chart · PNG
CRNX r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 4,314.683% | |
| 23,114.1482% | |
| 4,199.5265% | |
| 2,749.1028% | |
| 7,815.8627% | |
| 81,123.9437% | |
| 3,479.1282% | |
| 1,008.196% | |
| 451.4914% | |
| 865.8744% |